Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$21.94 - $26.24 $79,751 - $95,382
3,635 Added 1652.27%
3,855 $100,000
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $4,840 - $7,011
220 New
220 $5,000
Q1 2022

May 16, 2022

SELL
$23.07 - $27.99 $1.12 Million - $1.36 Million
-48,490 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$21.47 - $32.08 $1.04 Million - $1.56 Million
48,490 New
48,490 $1.13 Million
Q2 2020

Aug 14, 2020

SELL
$13.31 - $19.41 $137,239 - $200,136
-10,311 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$13.06 - $21.24 $122,659 - $199,486
-9,392 Reduced 47.67%
10,311 $149,000
Q2 2019

Aug 14, 2019

BUY
$21.47 - $37.33 $423,023 - $735,512
19,703 New
19,703 $444,000
Q1 2019

May 15, 2019

SELL
$28.4 - $36.49 $1,249 - $1,605
-44 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$27.94 - $44.61 $2.34 Million - $3.74 Million
-83,861 Reduced 99.95%
44 $1,000
Q3 2018

Nov 14, 2018

BUY
$38.6 - $46.12 $1.06 Million - $1.27 Million
27,531 Added 48.84%
83,905 $3.56 Million
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $2.2 Million - $2.78 Million
54,147 Added 2431.39%
56,374 $2.32 Million
Q1 2018

May 15, 2018

BUY
$53.61 - $67.26 $119,389 - $149,788
2,227 New
2,227 $129,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.